HLS Therapeutics Inc T.HLS

Alternate Symbol(s): HLTRF

HLS Therapeutics Inc. is a pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. It is engaged in addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. It is also focused on products targeting the central nervous system and cardiovascular therapeutic areas. Its products include Clozaril, CSAN Pronto, MyCare Psychiatry and Vascepa. Its Clozaril is an atypical antipsychotic indicated for the management of symptoms of treatment-resistant schizophrenia for the Canadian and United States markets. CSAN Pronto is a capillary point-of-care medical device designed to enhance and simplify the mandatory safety blood monitoring process for patients that are prescribed Clozaril. The Vascepa (icosapent ethyl capsules) is a single-molecule prescription product in use to reduce the risk of cardiovascular events.

TSX:HLS - Post by User

HLS Therapeutics Inc

Bullboard Posts

Comment by fairweather1on Sep 20, 2013 2:06pm

150 Views

Post# 21755333

RE:RE:RE:Ford announces Oakville upgrade, creating 2800 jobs

I don't know that the Ford report, nor the severance expectation you identify is really news in that Ford telegraphed their intentions long ago (and yes, you are right the title is "spin"), but AM has accounted for the severance I think with 4.5 million already banked and a further, smiilar amount planned for next year, though I think next year's closure amount is what they are trying to reduce by moving some equipment and bodies if possible.

Bullboard Posts

Record Q3: Equinox Gold achieves commercial production at Greenstone Mine